101 related articles for article (PubMed ID: 26820527)
1. Role of protein kinase A and class II phosphatidylinositol 3-kinase C2β in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide.
Choi JY; Park S
Biochem Biophys Res Commun; 2016 Feb; 470(4):907-12. PubMed ID: 26820527
[TBL] [Abstract][Full Text] [Related]
2. Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts.
Choi JY; Shin MY; Suh SH; Park S
Biochem Biophys Res Commun; 2015 Dec; 468(4):883-8. PubMed ID: 26592662
[TBL] [Abstract][Full Text] [Related]
3. The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells.
Srivastava S; Di L; Zhdanova O; Li Z; Vardhana S; Wan Q; Yan Y; Varma R; Backer J; Wulff H; Dustin ML; Skolnik EY
Mol Biol Cell; 2009 Sep; 20(17):3783-91. PubMed ID: 19587117
[TBL] [Abstract][Full Text] [Related]
4. Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in fabry disease.
Choi S; Kim JA; Na HY; Cho SE; Park S; Jung SC; Suh SH
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):81-9. PubMed ID: 24158513
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.
Tuttolomondo A; Simonetta I; Riolo R; Todaro F; Di Chiara T; Miceli S; Pinto A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576250
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Srivastava S; Choudhury P; Li Z; Liu G; Nadkarni V; Ko K; Coetzee WA; Skolnik EY
Mol Biol Cell; 2006 Jan; 17(1):146-54. PubMed ID: 16251351
[TBL] [Abstract][Full Text] [Related]
8. Protein Kinase A-Mediated Suppression of the Slow Afterhyperpolarizing KCa3.1 Current in Temporal Lobe Epilepsy.
Tiwari MN; Mohan S; Biala Y; Yaari Y
J Neurosci; 2019 Dec; 39(50):9914-9926. PubMed ID: 31672789
[TBL] [Abstract][Full Text] [Related]
9. Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease.
Park S; Kim JA; Joo KY; Choi S; Choi EN; Shin JA; Han KH; Jung SC; Suh SH
Cardiovasc Res; 2011 Feb; 89(2):290-9. PubMed ID: 20971723
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide.
Jeon YJ; Jung N; Park JW; Park HY; Jung SC
PLoS One; 2015; 10(8):e0136442. PubMed ID: 26291612
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
12. LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells.
Caglioti C; Palazzetti F; Monarca L; Lobello R; Ceccarini MR; Iannitti RG; Russo R; Ragonese F; Pennetta C; De Luca A; Codini M; Fioretti B
Front Physiol; 2021; 12():790922. PubMed ID: 35069252
[TBL] [Abstract][Full Text] [Related]
13. RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death.
Kim SY; Park S; Lee SW; Lee JH; Lee ES; Kim M; Kim Y; Kang JS; Chung CH; Moon JS; Lee EY
Cells; 2021 Jan; 10(2):. PubMed ID: 33513913
[TBL] [Abstract][Full Text] [Related]
14. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Wong R; Schlichter LC
J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816
[TBL] [Abstract][Full Text] [Related]
15. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
Hansen LK
Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
[TBL] [Abstract][Full Text] [Related]
16. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β.
Cai X; Srivastava S; Sun Y; Li Z; Wu H; Zuvela-Jelaska L; Li J; Salamon RS; Backer JM; Skolnik EY
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20072-7. PubMed ID: 22128329
[TBL] [Abstract][Full Text] [Related]
17. Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb₃-related analogues in Fabry disease.
Boutin M; Auray-Blais C
Anal Chem; 2014 Apr; 86(7):3476-83. PubMed ID: 24634980
[TBL] [Abstract][Full Text] [Related]
18. Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease.
Togawa T; Kawashima I; Kodama T; Tsukimura T; Suzuki T; Fukushige T; Kanekura T; Sakuraba H
Biochem Biophys Res Commun; 2010 Sep; 399(4):716-20. PubMed ID: 20692233
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease.
Srivastava S; Li Z; Skolnik EY
PLoS One; 2017; 12(8):e0183474. PubMed ID: 28820911
[TBL] [Abstract][Full Text] [Related]
20. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
